Psyence Group Inc.

CSE: PSYG

Company Logo

Company Overview

The Psyence Group has built and operates one of the first federally-licensed commercial psilocybin cultivation and production facilities. 

The Psyence network, team and operations are located across Toronto (Canada), Washington DC (United States of America), Cape Town (South Africa), Lesotho (Kingdom of Lesotho), Kingston (Jamaica), London (United Kingdom), Sydney (Australia) and Sao Paulo (Brazil).

The company operates in four division:

  • Psyence Therapeutics: Medicinal formulations and therapies to treat mental health disorders in a clinical environment.
  • Psyence Production: The first commercially licensed and scalable non-synthetic GMP psilocybin cultivation and processing facility.
  • Psyence Experience: Premium retreats in Jamaica and Southern Africa reconnect people to nature, nourishing mind and body, and elevating consciousness.
  • Psyence Function: Industry-leading health and wellbeing products that support the Psyence purpose and are based on proprietary formulations.

Financial Highlights

$0

Revenue (ttm)

$0

Gross Profit (ttm)

-$0.22

Diluted EPS (ttm)

Management Team

Mr. Jody Aufrichtig
Co-Founder & Exec. Chairman

Mr. Alan Mark Friedman B.Com., Bcomm, Bproc Law
Co-Founder & Director

Mr. Warwick Corden-Lloyd
CFO & Corp. Sec.

Dr. Amza Ali M.D.
Director & Chief Medical Officer

Dr. Neil Maresky M.D.
Chief Exec. Officer

Mr. Mike Dacks
Chief Operating Officer

Dr. Justin Grant M.B.A., Ph.D., MBA
Chief Scientific Officer

Ms. Taryn Vos
Gen. Counsel

Dr. Dingle Spence B.Sc., M.D., MBBS
Chief Medical Officer of Psyence Jamaica

Mr. Tony Budden
Chief Strategy Officer

Sign Up for Alerts

Receive an email alert every time a company announces a merger, capital raise or files for an IPO.

Company Profile

Website

Twitter

Presentation

Key Highlights

Market Capitalization
$0

Shares Outstanding
0

Shares Short (% of Float)
()

Insider Ownership
13%